z-logo
Premium
Combination of total length of Gleason pattern 4 and number of Gleason score 3 + 4 = 7 cores detects similar outcome group to Gleason score 6 cancers among cases with ≥5% of Gleason pattern 4
Author(s) -
Sato Shun,
Kimura Takahiro,
Onuma Hajime,
Fukuda Yumiko,
Egawa Shin,
Takahashi Hiroyuki
Publication year - 2020
Publication title -
pathology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 74
eISSN - 1440-1827
pISSN - 1320-5463
DOI - 10.1111/pin.13026
Subject(s) - biochemical recurrence , prostate cancer , prostatectomy , medicine , breakpoint cluster region , biopsy , cancer , oncology , pathology , urology , receptor
Expanding the inclusion criteria for active prostate cancer surveillance to include cases with a Gleason score (GS) of 3 + 4 = 7 has been discussed. GS 3 + 4 = 7 cases with a percentage of Gleason pattern 4 (%GP4) <5% were shown to be associated with similar outcomes with those of GS 6 cases. We examined the clinicopathological significance of %GP4 ≥5% with a limited amount of GP4. A total of 315 radical prostatectomy cases with GS 6 or 3 + 4 = 7 in a prior biopsy, were reviewed. The cases with the highest %GP4 ≥5% were subcategorized using the total length of GP4 (GP4‐TL) and number of GS 3 + 4 = 7 cores. As outcome measures, the frequency of adverse pathology (AP) and the risk of biochemical recurrence (BCR) were compared between the GS 6 and 3 + 4 = 7 subgroups. In the %GP4 ≥5% subgroup, only cases with both GP4‐TL <0.5 mm and 1 core of GS 3 + 4 = 7 showed similar outcome measures with those of GS 6 cancers. However, all other subgroups showed a higher frequency of AP and/or risk of BCR than GS 6 cancers. Our results suggest that cases with %GP4 ≥5% with a limited amount of GP4 should be considered for inclusion in the active surveillance category.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here